Inquiry Basket
Antibody-Drug Conjugates (ADCs) combines the high specificity of monoclonal antibody drugs with the high activity of small molecule cytotoxic drugs to improve the targeting of cancer drugs and reduce toxic side effects. The mechanism of action involves using monoclonal antibodies to specifically target cancer cells, and kill the cancer cells by coupled small molecule drugs. BOC Sciences has an extensive catalog of ADC cytotoxins, including commercially available compounds and custom synthesis options. We offer a wide range of potent cytotoxic drugs that can be combined with antibodies for targeted cancer therapy.
